India’s biotechnology sector has, over the past decade, evolved into a key driver of economic growth, innovation and sustainability. This transformation has been systematically captured through the India BioEconomy Report (IBER), an initiative that began in 2016 as a focused effort by ABLE to assess the economic contribution of biotechnology across critical sectors. Building on ABLE’s early vision articulated in 2012, the research team developed methodologies tailored to India’s unique biotechnology landscape, drawing upon global academic and policy frameworks. The India BioEconomy Report 2026 marks the 10th edition of this flagship publication. Over the years, the analytical framework has matured into a robust and structured exercise, strengthened through sustained engagement with industry leaders, domain experts and policymakers. The report now comprehensively tracks biotechnology-enabled economic activity across BioPharma, BioAgri, BioIndustrial and BioServices, while also capturing the growth of India’s expanding biotech startup ecosystem. We gratefully acknowledge the continued support of the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC).

As we mark this important milestone, ABLE remains committed to fostering cross-sectoral innovation. In this context, the Center of Excellence (CoE) Space Tech Foundation, in collaboration with ABLE, has launched the “Space to Society” webinar series to bridge the interface between the space sector and mainstream industries. The inaugural session on “Biomanufacturing in Space – India’s Road to the Next Frontier” underscored emerging opportunities at this convergence.

Global engagement continues to remain a priority. We encourage stakeholders to participate in the BIO International Convention 2026, where ABLE is organizing the India Pavilion in collaboration with 3SMG Private Limited. The pavilion will provide a high-visibility platform for Indian companies to showcase innovations and build international partnerships. The steady expansion of India’s BioEconomy reflects the collective efforts of academia, industry and government. ABLE remains committed to advancing this momentum and strengthening India’s position as a global biotechnology leader.